Diabetes Care, Vol 18, Issue 12 1550-1556, Copyright © 1995 by American Diabetes Association
Maternal serum triglyceride, glucose tolerance, and neonatal birth weight ratio in pregnancy
CJ Nolan, SF Riley, MT Sheedy, JE Walstab and NA Beischer
Department of Medicine, University of Melbourne, Victoria, Australia.
OBJECTIVE: To determine the value of measuring serum triglyceride (TG)
levels early in pregnancy for predicting late-gestation glucose tolerance
and neonatal birth weight ratio (BWR) (birth weight corrected for
gestational age). RESEARCH DESIGN AND METHODS: The relationships between
morning nonfasting TG measured early in pregnancy (gestational age 12 +/- 6
weeks [mean +/- SD]) and glucose tolerance measured by a 3-h 50-g oral
glucose tolerance test (OGTT) late in pregnancy (gestational age 30 +/- 3
weeks) and BWR were investigated in 388 women attending routine antenatal
care. The data were analyzed for all women in addition to subgroups of
Australian/Western European-born (n = 246) and Asian-born (n = 97) women.
RESULTS: Morning nonfasting TG positively correlated with the OGTT glucose
area under the curve (OGTT-GAUC) (r = 0.23, P < 0.0001) in all subjects.
This correlation was stronger in the subset of subjects who had TG measured
between 9 and 12 weeks of gestation (r = 0.35, P = 0.0001) and was
particularly strong in Asian-born women who had TG measured within this
period (r = 0.71, P < 0.0001). Mean TG and the 2- and 3-h OGTT values
were higher in Asian-born subjects compared with Australian/Western
European-born subjects (P = 0.004, P < 0.0001, and P = 0.02,
respectively). TG correlated positively with BWR in all subjects (r = 0.12,
P = 0.02), in Asian-born subjects (r = 0.23, P = 0.02), and in subjects
with gestational diabetes mellitus (GDM) (r = 0.60, P = < 0.001).
CONCLUSIONS: TG, if measured between 9 and 12 weeks of gestation, has
moderate predictive value for subsequent glucose tolerance in pregnancy. TG
is also predictive of BWR in GDM subjects. Further studies are warranted to
investigate the role of early TG measurement in the screening and
management of GDM. Metabolic heterogeneity exists between Asian-born and
Australian/Western European-born women, the significance of which is still
unclear and warrants further study.